RxDoctor Payments DataLook up a doctor →

Siamak Moghadam-Kia

Rheumatology · Pittsburgh, PANPI 1528294188

Payments from drug & device makers

$1,888,973in general payments, 2019–2025

Across 268 payments — averaging $7048.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • CSL Behring$1.5M
  • Argenx US, Inc.$156K
  • Pfizer$150K
  • AstraZeneca$34K
  • Janssen Research & Development, LLC$25K
  • Boehringer Ingelheim$3K
  • plus $3K from 6 others
$61in research payments, 2019–2025

Across 2 payments — averaging $30.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • CSL Behring$61

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
CSL Behring156$1,518,107
Argenx US, Inc.86$155,942
Pfizer1$149,558
AstraZeneca3$33,770
Janssen Research & Development, LLC2$25,498
Boehringer Ingelheim5$2,744
UCB SA9$1,670
Vertex2$1,067
AbbVie1$400
Cardinal Health 110 LLC1$100
UCB, Inc.1$78
GSK1$40

How this compares

$1,888,973 in reported general payments places this provider in the 95th percentile of 351 rheumatology providers in Pennsylvania.

See all rheumatology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$14,376
Medicare patients
79
Services billed
164

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other rheumatology in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →